
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.
Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.
Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.
Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.
Serving as the driver of the development of the global strategic publication plan for one or more rare disease therapeutic areas, the Associate Director of Global Scientific Publication Planning oversees the planning, execution, and amplification of scientific publications, including abstracts, posters, oral presentations, manuscripts, and publication extenders. The Associate Director will collaborate cross-functionally to understand the medical communications needs across the organization and will represent the Publication Planning function across departments.
First preference is for someone who can work hybrid from Princeton, NJ but remote candidates may be considered. This role will report to the Director, Global Head of Publication Planning.
Key Responsibilities
Requirements
Estimated compensation $170-190K/year DOE
Benefits
A note to recruiters:
We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from: Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs your ownership of these candidates will not be acknowledged.

Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.